Cargando...
Therapeutic advances in idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is characterised by progressive accumulation of scar tissue in the lung and is associated with a median life expectancy of 2–4 years. Until recently, treatment options were limited, focusing on ineffective anti-inflammatory therapy, palliation, transplant or trial...
Guardado en:
| Publicado en: | Clin Med (Lond) |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Royal College of Physicians
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4954329/ https://ncbi.nlm.nih.gov/pubmed/26833513 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7861/clinmedicine.16-1-42 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|